Tag Archives: ICPT

Hot Clean Energy Stocks To Invest In Right Now

General Electric (NYSE:GE) is one of the most outstanding dividend plays out there. Not only has the company paid out a dividend for more than 100 uninterrupted years, it has also grown that dividend in most years. GE’s current yield of 3% is considerably higher than the Dow Jones Industrial Average (INDX:INDU) average yield of 2.76%.

Anything that would threaten that dividend is, therefore,....More>>>

Top Gold Stocks To Own Right Now

Related NORW No Refuge With Nordic ETFs International ETFs For Oil Rebound
Related BNO It'll Be A While Before Saudi Arabia Gets An EM Upgrade Mixed News On Russia's Dividend Outlook Goldman Sachs Gets Oil Religion – Why It May Be Too Giddy In Its Short-Term Outlook (Seeking Alpha) ....More>>>

Top Casino Stocks To Buy For 2019

Check out the companies making headlines before the bell:

Bank of America The bank reported quarterly profit of 62 cents per share, 3 cents a share above estimates, with revenue also above forecasts. The bank’s results were helped by improved loan growth and deposits, among other factors.

WPP Group WPP founder and Chief Executive Officer Martin Sorrell has stepped down. Two....More>>>

Top Bank Stocks To Buy For 2019

Yes, it’s a rhetorical question, but Federal Reserve Chief Janet Yellen really isn’t doing financial stocks any favors. While her dovish comments today have proppelled the stock market to decent gains, financial stocks have not reacted with the same type of vigor.

Getty Images

The Financials Select Sector SPDR ETF (XLF) is little changed at $22.38 at 3:06 p.m. today, even....More>>>

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Biotechs companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single word from governing health care agencies, such as the U.S. Food and Drug Administration (FDA), can make or break these companies.

Analysts often weigh in on these companies, and there are a number of factors that play a role in how analysts view....More>>>

technical trading

Taxes needn’t be tough. When you boil it down, if you’re preparing your taxes, you compile everything you can deduct and try to save as much as you can.

But thieves know that they can get into your financial life by pressing the fear and hacking buttons. Although everybody wants some money back from the IRS, almost no one wants to hear from the agency.

Swindlers also know....More>>>

Top 5 Safest Stocks For 2018

Stocks discussed on the Lightning Round segment of Jim Cramer’s Mad Money Program, Monday, January 9.

Bullish Calls

EQT Midstream Partners (NYSE:EQT): It’s a good stock but Cramer prefers Magellan Midstream Partners (NYSE:MMP) which is also held by his trust.

Hormel Foods Corp (NYSE:HRL): It’s a long-term buy as they are transforming towards being organic.....More>>>

stock picking software

S&W Seed Company (NASDAQ:SANW) files its latest 10-K with SEC for the fiscal year ended on June 30, 2017. S&W Seed Co is engaged in breeding, growing, processing and selling of alfalfa seed. It also offers seed cleaning and processing for other seed manufacturers. Its products include Alfalfa seed varieties and Stevia. S&W Seed Company has a market cap of $65.130 million; its shares....More>>>

day trading training

Dont fight the trend is an oft-used expression on Wall Street. It may be truer now than ever. Casting a dubious eye on what has amounted to a spectacular rise for equity markets since Donald Trump became president-elect in November is proving a costly enterprise.

Whether the advance for equities can sustain itself over the next month and into 2017 is anyones guess, but for now investors who....More>>>

Intercept Pharmaceuticals Q2 Earnings: Beats But Shares Fall 13.26%

Small cap liver biopharmaceutical stock Intercept Pharmaceuticals Inc (NASDAQ: ICPT) reportedQ2 2017 earnings before the market opened on Monday with both the top and bottom lines beating expectations plus the Companyreported that amid-stage clinical trial met its primary endpoint; but sharesended the day down13.26%. Intercept Pharmaceuticals recognized $30.4 million of net sales of Ocaliva....More>>>